Page 945 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 945

676     PART 5: Infectious Disorders


                 infection in severe AIDS patients. It is believed that toxoplasmic enceph-  of inflammation and demyelination involving cerebral subcortical and
                 alitis results from reactivation of chronic latent infection seen in patients   deep cortical white matter, and gray matter.  Spontaneous recovery
                                                                                                        132
                 with CD4 counts less than 50 cells/µL.  However, with the introduc-  or recovery with corticosteroids is usually reported, though permanent
                                              124
                 tion of antiretroviral therapy and prophylaxis with trimethoprim-   sequelae can occur in few patients. Once infection is ruled out, the
                 sulfamethoxazole, the incidence is decreasing. Clinically, cerebral   recommended treatment regime is intravenous methylprednisolone 1 g
                 involvement is more common and takes the form of cerebral mass   daily with a cumulative dose of 3 to 5 g followed by 1 to 2 months of oral
                 lesions, meningoencephalitis, or diffuse encephalitis. The symptoms are   prednisolone on a tapering regimen. Plasma exchange and intravenous
                 nonspecific, and include fever, seizures, headache, hemiparesis, altered   immunoglobulin can be considered in patients who fail to respond to
                 mental status, and coma. CT or MRI of the brain in toxoplasmosis   corticosteroids. 130
                 shows multiple homogenous or ring-enhancing lesions with mass effect
                 commonly in the region of the basal ganglia, midbrain, or brainstem.
                 Imaging may be normal in diffuse toxoplasmosis. MRI is reportedly   KEY REFERENCES
                 more sensitive than CT.  The diagnostic serologic studies for toxoplas-
                                  125
                 mosis are seldom seen in AIDS patients. Detection of Toxoplasma DNA     • Centers for Disease Control and Prevention (CDC). Update:
                 on PCR testing of CSF may facilitate diagnosis and follow-up care. 126,127    measles–United States, January-July 2008. MMWR Morb Mortal
                 In AIDS patients with suspected toxoplasmic encephalitis, it is desirable   Wkly Rep. 2008;57(33):893-896.
                 to have a confirmed diagnosis because similar lesions may be due to     • Dedicoat M, Livesley N. Management of toxoplasmic encepha-
                 tuberculosis, other bacteria or fungi, or even lymphoma. Brain biopsy   litis in HIV-infected adults (with an emphasis on resource-poor
                 is reserved for patients who fail to respond to therapy or whose neuro-  settings). Cochrane Database Syst Rev. 2006;3:CD005420.
                 logic status is rapidly deteriorating. In AIDS patients with encephalitis     • Gilden DH, et al. Neurologic complications of the reactivation of
                 that is clinically and radiographically compatible with toxoplasmosis, a   varicella-zoster virus. N Engl J Med. 2000;342(9):635-645.
                 therapeutic trial with pyrimethamine and sulfadiazine should be initi-
                 ated early. The standard treatment regimen includes pyrimethamine,     • Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing panen-
                 folinic acid, and sulfadiazine. Trimethoprim-sulfamethoxazole can be   cephalitis: an update. Dev Med Child Neurol. 2010;52(10):901-907.
                 used as an alternative treatment and clindamycin can be used in sulfa     • Hatipoglu HG, Sakman B, Yuksel E.  Magnetic  resonance and
                 allergic patients.  Primary therapy is continued for at least 6 weeks.     diffusion-weighted imaging findings of herpes simplex encephali-
                             128
                 In AIDS patients, discontinuation of therapy has been associated   tis. Herpes. 2008;15(1):13-17.
                 frequently with relapse of toxoplasmic encephalitis, so maintenance     • Hayes EB, et al. Virology, pathology, and clinical manifestations of
                 therapy should be continued at reduced doses. The duration of main-  West Nile virus disease. Emerg Infect Dis. 2005;11(8):1174-1179.
                 tenance therapy depends on the response to highly active antiretroviral     • Hviid A, Rubin S, Muhlemann K. Mumps.  Lancet. 2008;
                 therapy (HAART) and can be discontinued when persistent CD4 counts
                 are greater than 200 cells/µL and if lesions have disappeared on MRI. 129  371(9616):932-944.
                                                                           • Kramer AH. Viral encephalitis in the ICU.  Crit Care Clin.
                                                                          2013;29:621-649.
                 POSTINFECTIOUS                                            • Lindquist L, Vapalahti O. Tick-borne encephalitis.  Lancet.
                     ■  ACUTE DISSEMINATED ENCEPHALOMYELITIS              2008;371(9627):1861-1871.

                 Acute disseminated encephalomyelitis (ADEM) is an inflammatory     • Tunkel AR, et al. The management of encephalitis: clinical prac-
                 demyelinating disease of the central nervous system. It is usually mono-  tice guidelines by the Infectious Diseases Society of America. Clin
                 phasic  but  a  multiphasic  variety  has  also  been  recognized.   ADEM   Infect Dis. 2008;47(3):303-327.
                                                             130
                 includes postinfectious and postvaccination encephalomyelitis, which     • Whitley RJ, et al. Vidarabine versus acyclovir therapy in herpes
                 together make up more than three-quarters of cases of ADEM. ADEM   simplex encephalitis. N Engl J Med. 1986;314(3):144-149.
                 is one  of the  categories  of the  inflammatory demyelinating diseases,
                 others  being  multiple  sclerosis,  transverse  myelitis,  optic  neuropathy,
                 and neuromyelitis optica  (Devic  disease).  Postinfectious ADEM  has
                 been described with both viral and bacterial infections, including mea-  REFERENCES
                 sles, mumps, rubella, varicella-zoster, EBV, CMV, herpes simplex virus,   Complete references available online at www.mhprofessional.com/hall
                 hepatitis A or B, coxsackievirus, influenza A or B, human immunode-
                 ficiency  virus  (HIV),  human  T-cell  lymphotropic  virus-1  (HTLV-1),
                 human herpes virus 6, Rocky Mountain spotted fever, human corona
                 virus,  Mycoplasma pneumoniae,  Borrelia,  Campylobacter,  Leptospira,
                 Chlamydia, Legionella, and group A beta-hemolytic streptococci. ADEM   CHAPTER  Life-Threatening Infections
                 has been described postvaccination with rabies, mumps measles rubella,   of the Head, Neck, and
                 diphtheria pertussis, tetanus, polio, influenza, and hepatitis B vaccines.   73
                 ADEM has an estimated annual incidence of 0.8 per 100,000 with a   Upper Respiratory Tract
                 median age of onset of 6.5 years.  ADEM has a distinct pattern of
                                          131
                 perivenous inflammation surrounding small vessels in both the CNS   Anthony W. Chow
                 gray and white matter. Most of these lesions seem of similar age with
                 predominant lymphocytic infiltration. Eventual demyelination in a
                 “sleeve-like” fashion is pathognomic.  In ADEM, the timing of a febrile   KEY POINTS
                                            131
                 event is associated with the onset of neurological disease. Symptoms
                 occur rapidly with a combination of altered consciousness and multifo-    •  A thorough knowledge of the deep cervical fascial spaces and their
                 cal  neurological  deficits.  Multiple  sclerosis  (MS)  is  an  important  dif-  interrelationships and anatomic routes of spread is a prerequisite to
                 ferential for ADEM but encephalopathy, fever, seizures, and meningeal   optimal management of life-threatening head and neck infections.
                 signs are very rare in MS. Infection should be ruled out first with lumbar     •  The microbial etiology of deep infections of the head and neck is
                 puncture, microbiological and serological tests. MRI is the imaging   complex and typically polymicrobial.
                 modality of  choice and  shows scattered,  focal, or  disseminated areas








            section05_c61-73.indd   676                                                                                1/23/2015   12:48:47 PM
   940   941   942   943   944   945   946   947   948   949   950